Sanofi SA (ADR) (NYSE:SNY), which has recently been in the limelight for the much publicized ousting of its former CEO Christopher Viehbacher, expressed confidence in its drug pipeline in a statement today. It estimates its experimental drugs to bring in combined revenue of $37.6 billion over the next five years. Sanofi SA (ADR) (NYSE:SNY) belongs to Healthcare sector. Its net profit margin is 12.20% and … Continue reading Hot News: Sanofi SA (ADR) (NYSE:SNY), CBL & Associates Properties Inc. (NYSE:CBL), Quicksilver Resources Inc. (NYSE:KWK), BancorpSouth (NYSE:BXS), Advanced Semiconductor Engineering (NYSE:ASX)